APPLICABILITY OF THE INTERNATIONAL ATAXIA RATING SCALE (ICARS) IN YOUNGER PATIENTS AND DEVELOPMENT OF GLOBAL RATING INSTRUMENTS FOR PATIENTS WITH ATAXIA TELANGIECTASIA (AT)

Quince Therapeutics S.p.A.5 sites in 4 countries63 target enrollmentAugust 2013

ConditionsAtaxia Telangiectasia

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Ataxia Telangiectasia
Sponsor: Quince Therapeutics S.p.A.
Enrollment: 63
Locations: 5
Primary Endpoint: Correlation Analysis
Status: Completed
Last Updated: 11 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The project will collect information on the mapping of clinical ratings on a number of scales that are used in the assessment of patients with ataxias.

Registry

clinicaltrials.gov

Start Date

August 2013

End Date

May 2014

Last Updated

11 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Quince Therapeutics S.p.A.

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Outcomes

Primary Outcomes

Correlation Analysis

Time Frame: single visit

The primary outcome is validity of ICARS in children younger than 10 years of age (by comparing the mean scores and subscores between children aged 6-10 years of age to those aged 10-18 years of age).